Lactobacillus paracasei strain
US-12152232-B2 · Nov 26, 2024 · US
Lactobacillus plantarum and composition containing same
US9962417B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9962417-B2 |
| Application number | US-201615254599-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 1, 2016 |
| Priority date | Jul 14, 2009 |
| Publication date | May 8, 2018 |
| Grant date | May 8, 2018 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides Lactobacillus plantarum CJLP55 KCTC 11401BP, a composition for treating bowel disease containing the lactobacillus , and a composition for immunological enhancement containing the lactobacillus.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for treating an immune disease caused by a Th1/Th2 imbalance in favor of a Th2 shift in a subject, comprising: administering a composition comprising Lactobacillus plantarum CJLP55 to the subject in need thereof. 2. The method of claim 1 , wherein the composition is selected from the group consisting of pharmaceuticals, food, animal feed, feed additives and cosmetics. 3. The method of claim 1 , wherein the subject is a human. 4. The method of claim 1 , wherein the composition is administered orally. 5. A method for improving a microbial environment in a gastrointestinal tract of a subject, comprising: administering a composition comprising Lactobacillus plantarum CJLP55 to the subject in need thereof. 6. The method of claim 5 , wherein the composition is selected from the group consisting of pharmaceuticals, food, animal feed, feed additives and cosmetics. 7. The method of claim 5 , wherein the subject is a human. 8. The method of claim 5 , wherein the composition is administered orally. 9. A method for treating an immune disease in a subject, comprising: administering a composition comprising Lactobacillus plantarum CJLP55 to the subject in need thereof, wherein the immune disease is caused by a Th1/Th2 imbalance in favor of a Th2 shift and is selected from the group consisting of allergic diseases, atopy, cancer, and enteropathy. 10. The method of claim 9 , wherein the composition is selected from the group consisting of pharmaceuticals, food, animal feed, feed additives and cosmetics. 11. The method of claim 9 , wherein the subject is a human. 12. The method of claim 9 , wherein the composition is administered orally.
Assignees
Inventors
Classifications
Immunostimulants · CPC title
Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14) · CPC title
Immunosuppressants, e.g. drugs for graft rejection · CPC title
Antineoplastic agents · CPC title
Drugs for immunological or allergic disorders · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9962417B2 cover?
- The present invention provides Lactobacillus plantarum CJLP55 KCTC 11401BP, a composition for treating bowel disease containing the lactobacillus , and a composition for immunological enhancement containing the lactobacillus.
- Who is the assignee on this patent?
- Cj Cheiljedang Corp
- What technology area does this patent fall under?
- Primary CPC classification A61K35/747. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).